SCHEMBL3607930

SCHEMBL3607930

O=C(CCCNC(=O)Cc1csc(N(Cc2cccnc2)C(=O)O)n1)NO

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTO1 P78417 1/20 0.44
PDE5A O76074 2/20 0.44
PDE1A P54750 1/20 0.44
PDE1B Q01064 1/20 0.44
PDE1C Q14123 1/20 0.44
HDAC1 Q13547 9/20 0.43
HDAC6 Q9UBN7 8/20 0.43
SMN1; SMN2 Q16637 1/20 0.41
NAMPT P43490 1/20 0.40
EPHX2 P34913 1/20 0.40
HDAC8 Q9BY41 3/20 0.39
HDAC3 O15379 2/20 0.39
HDAC4 P56524 2/20 0.39
HDAC7 Q8WUI4 2/20 0.39
HDAC2 Q92769 2/20 0.39
HDAC10 Q969S8 2/20 0.39
HDAC11 Q96DB2 2/20 0.39
HDAC9 Q9UKV0 2/20 0.39
HDAC5 Q9UQL6 2/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3608182 0.96 HDAC6 (0.47) GSTO1PDE5APDE1APDE1BPDE1C
SCHEMBL3600139 0.90 GSTO1 (0.52) GSTO1PDE5APDE1APDE1BPDE1C
SCHEMBL3600706 0.89 PDE5A (0.43) PDE5APDE1APDE1BPDE1CHDAC1
SCHEMBL3602419 0.86 PDE5A (0.46) PDE5APDE1APDE1BPDE1CHDAC1
SCHEMBL3614294 0.82 GSTO1 (0.50) GSTO1MAPT
SCHEMBL3618263 0.81 PDE5A (0.39) PDE5APDE1APDE1BPDE1CHDAC1
SCHEMBL3599486 0.80 HDAC1 (0.42) PDE5APDE1APDE1BPDE1CHDAC1
SCHEMBL3618083 0.79 HDAC1 (0.44) PDE5APDE1APDE1BPDE1CHDAC1
SCHEMBL3613733 0.78 PDE5A (0.39) PDE5APDE1APDE1BPDE1CHDAC1
SCHEMBL3601049 0.77 GSTO1 (0.48) GSTO1HDAC3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152188-A1 Novel Heterocyclic Compounds ORCHID RESEARCH LABORATORIES LIMITED (IN) 2010-06-17 US claimed
WO-2007017728-A2 NOVEL HETEROCYCLIC COMPOUNDS ORCHID RESEARCH LABORATORIES LIMITED (IN) 2007-02-15 WO claimed
US-20100152188-A1 Novel Heterocyclic Compounds ORCHID RESEARCH LABORATORIES LIMITED (IN) 2010-06-17 US disclosed
WO-2007017728-A2 NOVEL HETEROCYCLIC COMPOUNDS ORCHID RESEARCH LABORATORIES LIMITED (IN) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152188-A1 Novel Heterocyclic Compounds CYP11B2, CYP3A5, CYP11B1 GSTO1 3849/4885PDE5A 258/4885PDE1A 3451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.